Cooke, Timothy M.
Sofocleous, Constantinos T.
Petre, Elena N.
Alexander, Erica S.
Ziv, Etay
Solomon, Stephen B.
Sotirchos, Vlasios S. https://orcid.org/0000-0001-7278-1369
Funding for this research was provided by:
NIH/NCI (P30 CA008748)
Article History
Received: 27 November 2024
Accepted: 25 March 2025
First Online: 28 April 2025
Declarations
:
: C.T.S. is a paid consultant for Ethicon, Medtronic, Terumo, Boston Scientific/BTG, SIRTEX Medical Inc and Varian. He has received grants or contracts from the National Institutes of Health, Society of Interventional Oncology, Society of Interventional Radiology Foundation, Varian, Ethicon J&J, Boston Scientific/BTG, SIRTEX Medical Inc. E.S.A. is a paid consultant for Boston Scientific. E.Z. receives grant support from Ethicon, AACR-NETF, Memorial Sloan Kettering Cancer Center, Society of Interventional Radiology, Radiographic Society of North America, North American Neuroendocrine Tumor Society, Ethicon, Novartis and TOW Center. S.B.S. is a paid consultant for GE Healthcare, Merck and Obsidian; receives grants or contracts from Ethicon, GE Healthcare and Johnson & Johnson; and reports participation in data safety monitoring board of Candel Therapeutics and Impact Biotech, stock or stock options in Johnson & Johnson. The remaining authors declare that they have no conflict of interest.
: Institutional review board (IRB) waiver of approval was obtained for this retrospective cohort study (MSKCC: 16-402).
: Institutional review board (IRB) waiver of approval was obtained for this retrospective cohort study (MSKCC: 16-402).
: Consent for publication was obtained for every individual person’s data included in the study.